![Company](https://d2qa4785ekzzy0.cloudfront.net/typo3temp/assets/images/csm_CMN_Companies_to_Follow_2023_01_17_81d7a58868_1c503a0f51.png)
Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.
Always stay updated with the free CMN Newsletter.
Biomedrex Genetics
Main focus: Next-generation CRISPR-based antiviral therapies
Company stage: Pre-clinical
Diseases (gene editing): HIV-1, influenza, SARS-CoV-2
Genome editing tool: CRISPR
Funding stage: Private
Location: Huddinge, Sweden
Website: https://www.biomedrex.com/index.html
![](https://d2qa4785ekzzy0.cloudfront.net/typo3temp/assets/images/csm_biomedrex-blue__1__0e05ebda2f_d6f5763f3e.png)
Biomedrex Genetics is a start-up company that develops novel antiviral treatments based on the CRISPR-Cas system. The company aims to treat various infectious diseases, with HIV-1 being the lead viral target. The company is currently conducting pre-clinical testing.